XENOTHERA therapeutic farm, unique in France and across Europe, is featured in a major report published by Les Échos Week-End on April 24, 2026
Our 500 animals are raised under exceptional sanitary conditions, with one ambition: paving the way for animal-to-human organ transplantation. The report highlights the concrete challenges of xenotransplantation in France. It also showcases what XENOTHERA, at the heart of the XENOCURE consortium, is already developing today, notably its LIS1 antibody, administered during allografts to neutralize the immune system’s immediate response. It has received orphan drug designation in both the United States and Europe.
Read More[Press Information] Orphan designation by the European Medicines Agency for LIS1, the transplant induction therapy from XENOTHERA
July 11th, 2022. # Download our press information (english version) # Télécharger...
Read More[Press Alert] XENOTHERA announces the efficacy of its XAV-19 antibody against the BQ.1.1variant.
December 19, 2022. # Download our press alert (english version) # Télécharger...
Read More[Newsletter] XENONEWS
November 2022. >> Official XENOTHERA’s newsletter /Lettre d’information officielle de XENOTHERA <<...
Read More[Press Information] Orphan designation by the European Medicines Agency for LIS1, the transplant induction therapy from XENOTHERA
July 11th, 2022. # Download our press information (english version) # Télécharger...
Read More[Newsletter] XENONEWS
June 2022. >> Official XENOTHERA’s newsletter /Lettre d’information officielle de XENOTHERA <<...
Read More[Press Information] XENOTHERA presents LIS1 results at the American Transplant Congress (ATC) in Boston
May 2022. # Download our press information (english version) # Télécharger notre...
Read More[Press Alert] Safety and efficacy results of LIS1
June 2022. # Download our press information (english version) # Télécharger notre...
Read More[Press information] XENOTHERA announces the continuation of development of its anti-SARS-CoV-2 antibody.
January 2022. # Download our press information (english version) # Télécharger notre...
Read More[Newsletter] XENONEWS
February 2022. >> Official XENOTHERA’s newsletter /Lettre d’information officielle de XENOTHERA <<...
Read More[Newsletter] XENONEWS
December 2021. >> Official XENOTHERA’s newsletter /Lettre d’information officielle de XENOTHERA <<...
Read More[Newsletter] XENONEWS
May 2021 >> Official XENOTHERA newsletter /Lettre d’information officielle de XENOTHERA <<...
Read More[Press Alert] Omicron Variant : positive results for XENOTHERA's XAV-19 antibody
December 2021. # Download our press information (english version) # Télécharger notre...
Read More[Infography/Infographie] Covid19
# 5 KEY POINTS TO KNOW ABOUT ANTIBODIES # Available here #...
Read More[Press Alert] XENOTHERA, Nantes University Hospital and the University of Nantes announce the signature of a consortium agreement within the framework of PSPC-COVID.
July 15, 2020. # Download our press release (english version) # Télécharger...
Read More[Newsletter - 8] NEWS/INFOS
July 17,2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19 <<...
Read More[Newsletter - 7] NEWS/INFOS
June 26, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...
Read More[Alerte actualité] Financement XENOTHERA
15 Juin 2020. Download the press release /Télécharger le communiqué
Read More[Newsletter-5] NEWS/INFOS
May 29, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...
Read MoreIn the News/ A la une
Pays de la Loire (ma région) –Interview vidéo d’Odile Duvaux – Coronavirus...
Read More[Newsletter -4] NEWS/INFOS
May 22, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...
Read More[Newsletter -3] NEWS/INFOS
May 15, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...
Read More[Newsletter -2] NEWS /INFOS
May 8, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...
Read More[Alerte actualité] Anticorps XAV19
30 avril 2020 Download the press release / Télécharger le communiqué
Read More